Good News Update!
24 SEPTEMBER 2021 • Ontario government approves coverage for Trikafta in people with CF, who are age 12 or older and have at least one copy of the F508del (also known as deltaF508 or “delta F”) mutation. At the moment, only people with FEV1 of < 90% predicted will be eligible for Trikafta.
This is wonderful news and an incredibly fast response from the government. From Health Canada approval to agreement by the province to cover has occurred in only 3 months! This is a testament to the advocacy work done by the CF community.